98 related articles for article (PubMed ID: 21782838)
41. Metabolic studies of turinabol in horses.
Ho EN; Kwok WH; Leung DK; Wan TS; Wong AS
Anal Chim Acta; 2007 Mar; 586(1-2):208-16. PubMed ID: 17386713
[TBL] [Abstract][Full Text] [Related]
42. Stability studies of testosterone and epitestosterone glucuronides in urine.
Jiménez C; de la Torre R; Segura J; Ventura R
Rapid Commun Mass Spectrom; 2006; 20(5):858-64. PubMed ID: 16470578
[TBL] [Abstract][Full Text] [Related]
43. Effect of the biological matrix on the urinary testosterone/epitestosterone ratio measured by gas chromatography/mass spectrometry in doping analysis.
Linnet K
Biol Mass Spectrom; 1993 Jul; 22(7):412-8. PubMed ID: 8357856
[TBL] [Abstract][Full Text] [Related]
44. Increased urinary testosterone/epitestosterone ratios found in Swedish athletes in connection with a national control program. Evaluation of 28 cases.
Garle M; Ocka R; Palonek E; Björkhem I
J Chromatogr B Biomed Appl; 1996 Dec; 687(1):55-9. PubMed ID: 9001952
[TBL] [Abstract][Full Text] [Related]
45. From population- to subject-based limits of T/E ratio to detect testosterone abuse in elite sports.
Sottas PE; Saudan C; Schweizer C; Baume N; Mangin P; Saugy M
Forensic Sci Int; 2008 Jan; 174(2-3):166-72. PubMed ID: 17485185
[TBL] [Abstract][Full Text] [Related]
46. Fast screening of anabolic steroids and other banned doping substances in human urine by gas chromatography/tandem mass spectrometry.
Marcos J; Pascual JA; de la Torre X; Segura J
J Mass Spectrom; 2002 Oct; 37(10):1059-73. PubMed ID: 12375280
[TBL] [Abstract][Full Text] [Related]
47. Genotype-dependent metabolism of exogenous testosterone - new biomarkers result in prolonged detectability.
Piper T; Schänzer W; Thevis M
Drug Test Anal; 2016 Nov; 8(11-12):1163-1173. PubMed ID: 27649524
[TBL] [Abstract][Full Text] [Related]
48. Searching for new markers of endogenous steroid administration in athletes: "looking outside the metabolic box".
Cawley AT; Hine ER; Trout GJ; George AV; Kazlauskas R
Forensic Sci Int; 2004 Jul; 143(2-3):103-14. PubMed ID: 15240029
[TBL] [Abstract][Full Text] [Related]
49. Toward the use of a molecularly imprinted polymer in doping analysis: selective preconcentration and analysis of testosterone and epitestosterone in human urine.
Tse Sum Bui B; Merlier F; Haupt K
Anal Chem; 2010 Jun; 82(11):4420-7. PubMed ID: 20438053
[TBL] [Abstract][Full Text] [Related]
50. Urinary testosterone (T) to epitestosterone (E) ratios by GC/MS. I. Initial comparison of uncorrected T/E in six international laboratories.
Catlin DH; Cowan DA; de la Torre R; Donike M; Fraisse D; Oftebro H; Hatton CK; Starcevic B; Becchi M; de la Torre X; Norli H; Geyer H; Walker CJ
J Mass Spectrom; 1996 Apr; 31(4):397-402. PubMed ID: 8799284
[TBL] [Abstract][Full Text] [Related]
51. [Study of urinary excretion of testosterone and epitestosterone glucuronides in children and adolescents].
Raynaud E; Audran M; Pages JC; Brun JF; Fedou C; Chanal JL; Orsetti A
Pathol Biol (Paris); 1993 Feb; 41(2):159-63. PubMed ID: 8327267
[TBL] [Abstract][Full Text] [Related]
52. Subject-based profiling for the detection of testosterone administration in sport.
Kicman AT; Cowan DA
Drug Test Anal; 2009 Jan; 1(1):22-4. PubMed ID: 20355155
[No Abstract] [Full Text] [Related]
53. Application of stable carbon isotope analysis to the detection of testosterone administration to cattle.
Hebestreit M; Flenker U; Buisson C; Andre F; Le Bizec B; Fry H; Lang M; Weigert AP; Heinrich K; Hird S; Schänzer W
J Agric Food Chem; 2006 Apr; 54(8):2850-8. PubMed ID: 16608200
[TBL] [Abstract][Full Text] [Related]
54. Metabolism of 4-hydroxyandrostenedione and 4-hydroxytestosterone: Mass spectrometric identification of urinary metabolites.
Kohler M; Parr MK; Opfermann G; Thevis M; Schlörer N; Marner FJ; Schänzer W
Steroids; 2007 Mar; 72(3):278-86. PubMed ID: 17207827
[TBL] [Abstract][Full Text] [Related]
55. Criteria to indicate testosterone administration.
Kicman AT; Brooks RV; Collyer SC; Cowan DA; Nanjee MN; Southan GJ; Wheeler MJ
Br J Sports Med; 1990 Dec; 24(4):253-64. PubMed ID: 2097025
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of equine urine reactivity towards phase II metabolites of 17-hydroxy steroids by liquid chromatography/tandem mass spectrometry.
Fidani M; Gamberini MC; Pasello E; Palazzoli F; De Iuliis P; Montana M; Arioli F
Rapid Commun Mass Spectrom; 2009 Jan; 23(1):65-76. PubMed ID: 19051232
[TBL] [Abstract][Full Text] [Related]
57. Substantial advantage of a combined Bayesian and genotyping approach in testosterone doping tests.
Schulze JJ; Lundmark J; Garle M; Ekström L; Sottas PE; Rane A
Steroids; 2009 Mar; 74(3):365-8. PubMed ID: 19056415
[TBL] [Abstract][Full Text] [Related]
58. Detection of simultaneous self-administration of testosterone and epitestosterone in healthy men.
Dehennin L
Clin Chem; 1994 Jan; 40(1):106-9. PubMed ID: 8287515
[TBL] [Abstract][Full Text] [Related]
59. Detection of anabolic steroid administration: ratio of urinary testosterone to epitestosterone vs the ratio of urinary testosterone to luteinizing hormone.
Perry PJ; MacIndoe JH; Yates WR; Scott SD; Holman TL
Clin Chem; 1997 May; 43(5):731-5. PubMed ID: 9166223
[TBL] [Abstract][Full Text] [Related]
60. Potential use of ketoconazole in a dynamic endocrine test to differentiate between biological outliers and testosterone use by athletes.
Kicman AT; Oftebro H; Walker C; Norman N; Cowan DA
Clin Chem; 1993 Sep; 39(9):1798-803. PubMed ID: 8375050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
